ES2125846T1 - Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes de virus de viruela o paravirus no inmunogenos atenuados como medicamentos. - Google Patents

Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes de virus de viruela o paravirus no inmunogenos atenuados como medicamentos.

Info

Publication number
ES2125846T1
ES2125846T1 ES97922838T ES97922838T ES2125846T1 ES 2125846 T1 ES2125846 T1 ES 2125846T1 ES 97922838 T ES97922838 T ES 97922838T ES 97922838 T ES97922838 T ES 97922838T ES 2125846 T1 ES2125846 T1 ES 2125846T1
Authority
ES
Spain
Prior art keywords
viruses
inductors
medicines
parimunity
attenued
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES97922838T
Other languages
English (en)
Other versions
ES2125846T3 (es
Inventor
Anton Prof Dr Med Vet Dr Mayr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES2125846T1 publication Critical patent/ES2125846T1/es
Application granted granted Critical
Publication of ES2125846T3 publication Critical patent/ES2125846T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Control Of El Displays (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE DESCRIBE EL EMPLEO DE UNOS INDUCTORES PARAINMUNOLOGICOS MULTIPOTENTES DE VIRUS VARIOLICOS O PARAVARIOLICOS (INDUCTORES VARIOLICOS) ATENUADOS Y NO INMUNOGENOS PARA LA PREPARACION DE UNOS MEDICAMENTOS PARA NUEVOS AMBITOS DE INDICACION EN LA MEDICINA HUMANA.
ES97922838T 1996-04-15 1997-04-14 Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes a partir de virus de viruela o virus de paraviruela atenuados, no inmunogenos, como medicamento. Expired - Lifetime ES2125846T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19614810 1996-04-15

Publications (2)

Publication Number Publication Date
ES2125846T1 true ES2125846T1 (es) 1999-03-16
ES2125846T3 ES2125846T3 (es) 2001-12-16

Family

ID=7791302

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97922838T Expired - Lifetime ES2125846T3 (es) 1996-04-15 1997-04-14 Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes a partir de virus de viruela o virus de paraviruela atenuados, no inmunogenos, como medicamento.

Country Status (20)

Country Link
US (1) US6162600A (es)
EP (1) EP0885013B1 (es)
JP (1) JP3568208B2 (es)
KR (1) KR100302994B1 (es)
CN (1) CN1165343C (es)
AT (1) ATE203678T1 (es)
AU (1) AU706729B2 (es)
BR (1) BR9708679A (es)
CA (1) CA2251690C (es)
DE (2) DE19780300D2 (es)
DK (1) DK0885013T3 (es)
ES (1) ES2125846T3 (es)
GR (1) GR3037049T3 (es)
HU (1) HU224308B1 (es)
NO (1) NO322176B1 (es)
NZ (1) NZ332243A (es)
PL (1) PL329353A1 (es)
PT (1) PT885013E (es)
SI (1) SI0885013T1 (es)
WO (1) WO1997038724A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1455674B (zh) * 2000-07-11 2019-03-29 艾库里斯有限及两合公司 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途
NZ523535A (en) * 2000-07-11 2004-12-24 Bayer Ag Use of strains of the Parapoxvirus ovis against organ fibroses
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
WO2003049683A2 (en) 2001-12-07 2003-06-19 Bayer Pharmacueticals Corporation Use of parapox b2l protein to treat cancer and modify immune responses
JP4897677B2 (ja) * 2004-07-13 2012-03-14 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト Ｈｉｖ／ａｉｄｓの処置用の他の抗ウイルス剤と組み合わせたパラポックスウイルス
DE102004045758A1 (de) * 2004-09-21 2006-04-06 Toximed Gmbh Pharmazeutischer Wirkstoff gegen das HIV-Syndrom
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504940C2 (de) * 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE19780300D2 (de) 1999-06-17
NO984782L (no) 1998-12-15
KR100302994B1 (ko) 2001-11-30
KR20000005479A (ko) 2000-01-25
EP0885013B1 (de) 2001-08-01
JP3568208B2 (ja) 2004-09-22
WO1997038724A1 (de) 1997-10-23
PT885013E (pt) 2002-01-30
HU224308B1 (hu) 2005-07-28
US6162600A (en) 2000-12-19
CA2251690C (en) 2005-11-08
NO984782D0 (no) 1998-10-14
HUP9901299A2 (hu) 1999-07-28
DK0885013T3 (da) 2001-11-05
ES2125846T3 (es) 2001-12-16
EP0885013A1 (de) 1998-12-23
CN1215996A (zh) 1999-05-05
GR3037049T3 (en) 2002-01-31
JP2000501114A (ja) 2000-02-02
AU2885897A (en) 1997-11-07
CN1165343C (zh) 2004-09-08
SI0885013T1 (es) 2001-12-31
NZ332243A (en) 2000-10-27
PL329353A1 (en) 1999-03-29
AU706729B2 (en) 1999-06-24
CA2251690A1 (en) 1997-10-23
NO322176B1 (no) 2006-08-21
DE59704194D1 (de) 2001-09-06
ATE203678T1 (de) 2001-08-15
BR9708679A (pt) 2000-01-04
HUP9901299A3 (en) 2000-03-28

Similar Documents

Publication Publication Date Title
ATE369346T1 (de) Halogenpyrimidinylaryl(thio)ether als pestizide
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
TR199900239T2 (es)
ES2122043T3 (es) Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas.
DE69003913D1 (de) Notbeatmungsgerät.
ES2063173T3 (es) Empleo de polietileniminas alquiladas como medicamentos absorbedores de acido biliar, asi como preparados farmaceuticos.
DE69930269D1 (de) Wasserlösslische prodrugs von gehinderten phenolen
ATE76069T1 (de) 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
DE3781177D1 (de) Gemischte phosphorsaeurediester, ihre herstellung und verwendung als entzuendungshemmende mittel.
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ES2094380T3 (es) Nuevos pirazolilpirazoles sustituidos, procedimientos para su preparacion, asi como compuestos intermedios, y su uso como herbicidas.
DK1313462T3 (da) Anvendelse af asiatisk syre eller asiaticosid til behandling af cancer
DE69914934D1 (de) Stabile wässrige insulinzubereitungen ohne phenol und kresol
ES2133412T3 (es) 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma.
ES2125846T1 (es) Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes de virus de viruela o paravirus no inmunogenos atenuados como medicamentos.
DE3761906D1 (de) Phosphor und fluoreszente, denselben verwendende lampe.
PT942896E (pt) Fenois e tiofenois substituidos uteis como agentes antioxidantes
DE3869202D1 (de) Alkylidendithiobis (substituierte) phenolen zur hemmung der freisetzung von interleukin-1 und zur linderung von interleukin-1 vermittelten krankheiten.
FR2692574B1 (fr) Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
AR005704A1 (es) Heteroariloxazolidinonas
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ATE298416T1 (de) Wasserwaage

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 885013

Country of ref document: ES